Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder

dc.authorscopusid57203415019
dc.authorscopusid15842197600
dc.authorscopusid55762448600
dc.authorscopusid57216198055
dc.authorscopusid57188867387
dc.authorscopusid7003926108
dc.authorscopusid26664394200
dc.authorwosidLes, Francisco/C-2272-2019
dc.authorwosidBUTNARIU, Monica/E-7217-2010
dc.authorwosidKirkin, Celale/ABF-4868-2021
dc.authorwosidKumar, Manoj/V-6829-2019
dc.authorwosidSemwal, Prabhakar/O-3924-2019
dc.authorwosidCruz-Martins, Natalia/P-2972-2015
dc.authorwosidOzcelik, Beraat/E-8446-2010
dc.contributor.authorCruz-Martins, Natalia
dc.contributor.authorQuispe, Cristina
dc.contributor.authorKirkin, Celale
dc.contributor.authorSenol, Ezgi
dc.contributor.authorZulug, Asli
dc.contributor.authorOzcelik, Beraat
dc.contributor.authorCho, William C.
dc.date.accessioned2022-03-04T19:12:18Z
dc.date.available2022-03-04T19:12:18Z
dc.date.issued2021
dc.departmentİZÜen_US
dc.description.abstractAutism spectrum disorder (ASD) is a neurodevelopmental disorder, where social and communication deficits and repetitive behaviors are present. Plant-derived bioactives have shown promising results in the treatment of autism. In this sense, this review is aimed at providing a careful view on the use of plant-derived bioactive molecules for the treatment of autism. Among the plethora of bioactives, curcumin, luteolin, and resveratrol have revealed excellent neuroprotective effects and can be effectively used in the treatment of neuropsychological disorders. However, the number of clinical trials is limited, and none of them have been approved for the treatment of autism or autism-related disorder. Further clinical studies are needed to effectively assess the real potential of such bioactive molecules.en_US
dc.description.sponsorshipPortuguese Foundation for Science and Technology under the Horizon 2020 Program [PTDC/PSI-GER/28076/2017]en_US
dc.description.sponsorshipN.C.-M. acknowledges the Portuguese Foundation for Science and Technology under the Horizon 2020 Program (PTDC/PSI-GER/28076/2017).en_US
dc.identifier.doi10.1155/2021/1131280
dc.identifier.issn1942-0900
dc.identifier.issn1942-0994
dc.identifier.orcidLes, Francisco/0000-0002-7972-7119
dc.identifier.orcidBUTNARIU, Monica/0000-0002-2032-5000
dc.identifier.orcidKumar, Manoj/0000-0002-4192-6497
dc.identifier.orcidKirkin, Celale/0000-0003-0736-4213
dc.identifier.orcidSemwal, Prabhakar/0000-0001-5137-5169
dc.identifier.orcidCruz-Martins, Natalia/0000-0002-5934-5201
dc.identifier.orcidOzcelik, Beraat/0000-0002-1810-8154
dc.identifier.pmid34471461en_US
dc.identifier.scopus2-s2.0-85114610989en_US
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1155/2021/1131280
dc.identifier.urihttps://hdl.handle.net/20.500.12436/3156
dc.identifier.volume2021en_US
dc.identifier.wosWOS:000692905700005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherHindawi Ltden_US
dc.relation.ispartofOxidative Medicine and Cellular Longevityen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPLACEBO-CONTROLLED TRIALen_US
dc.subjectOPEN-LABEL TRIALen_US
dc.subjectRANDOMIZED CONTROLLED-TRIALen_US
dc.subjectVALPROATE-INDUCED AUTISMen_US
dc.subjectALTERNATIVE MEDICINE USEen_US
dc.subjectYOUNG-CHILDRENen_US
dc.subjectDOUBLE-BLINDen_US
dc.subjectOXIDATIVE STRESSen_US
dc.subjectGINKGO-BILOBAen_US
dc.subjectVITAMIN-Den_US
dc.titlePaving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorderen_US
dc.typeReview Article
dspace.entity.typePublication

Dosyalar